S109: ACTIVATION OF PYRUVATE KINASE-R WITH ETAVOPIVAT (FT-4202) IS WELL TOLERATED, IMPROVES ANEMIA, AND DECREASES INTRAVASCULAR HEMOLYSIS IN PATIENTS WITH SICKLE CELL DISEASE TREAT... by M Telen, S Saraf, K Cruz, M Idowu, T Kalfa, I Osunkwo, R Hagar, J Geib, S Forsyth, P Schroeder, E Wu, P Kelly, R Brown

Get full text

P1495: ETAVOPIVAT TREATMENT FOR UP TO 12 WEEKS IN PATIENTS WITH SICKLE CELL DISEASE IS WELL TOLERATED AND IMPROVES RED BLOOD CELL HEALTH by S. Saraf, R. C. Brown, R. W. Hagar, M. Idowu, I. Osunkwo, T. A. Kalfa, F. A. Kuypers, J. Geib, P. Schroeder, E. Wu, P. Kelly, M. J. Telen

Get full text

S131: REGIONAL ASSESSMENT OF THE EXPERIENCES OF HEALTHCARE PROFESSIONALS (HCPS) TREATING PATIENTS WITH SICKLE CELL DISEASE (SCD): THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SUR... by I Osunkwo, B Andemariam, C Minniti, F El Rassi, E Nur, A Nero, R Colombatti, M de Montalembert, M Abboud, J Arlet, S Jain, W Jastaniah, M Pita, C Trimnell, L DeBonnett, T Bailey, O Rajkovic-Hooley, B Inusa, J James

Get full text

P1467: HEALTHCARE PROFESSIONALS (HCP) OPINIONS ON TREATMENTS FOR SICKLE CELL DISEASE (SCD) AND THE HCP–PATIENT RELATIONSHIP: RESULTS FROM THE INTERNATIONAL SICKLE CELL WORLD ASSESS... by B. Andemariam, J. James, C. Minniti, B. Inusa, F. El Rassi, A. Nero, C. Trimnell, M. R. Abboud, J.-B. Arlet, R. Colombatti, M. de Montalembert, S. Jain, W. Jastaniah, E. Nur, M. Pita, L. DeBonnett, T. Bailey, O. Rajkovic-Hooley, I. Osunkwo

Get full text